Transdermal Drug Delivery System Market is anticipated to reach USD 81.4 billion by 2024

 Global transdermal drug delivery system market is anticipated to reach USD 81.4 billion by 2024 owing to shift toward sedentary lifestyle that encourages chronic disorders. Transdermal drug delivery is a painless process of delivering drug in the body part. TDDS delivers drug through the skin in pre-decided and regulated rate. It offers extended therapeutic effects, lesser side-effects, improved patient compliance, better bioavailability, and easy cessation of drug treatment. Transdermal drug delivery is much preferred today as compared to the conventional oral method or injectables.


Transdermal drug delivery systems market is witnessing growth due to the factors like increasing consumer preference for minimally invasive procedures for chronic disorders and multiple advantages associated with TDDS. Infusion of drug could be effectively monitored and projected creditably through transdermal drug delivery method, which makes it convenient to maintain steady level of drug. However, transdermal drug delivery system industry is restrained by constrained areas of delivery and slow infusion rate hydrophilic drugs.


Download Free sample Report 

https://www.millioninsights.com/industry-reports/transdermal-drug-delivery-system-market/request-sample


Recent years has introduced multiple drugs that could be delivered through transdermal route. Also, the existing market players in this market are focusing on mergers and acquisition to create niche market.Transdermal drug delivery system market is categorized on the basis of delivery system type, application, and geography. On the basis of delivery system type, the market is divided into active (matrix system, reservoir system), passive (electrical based, structure based) and others. Electrical based systems can be further classified as iontophoresis, electroporation and sonophoresis. Passive delivery system segment is predicted to lead the market of transdermal drug delivery system due to rise in chronic disorders.


Based on application, transdermal drug delivery systems industry is divided into analgesics, hormone replacement therapy, motion sickness, cardiovascular disorder, smoking cessation, and others. Cardiovascular disorder segment is projected to hold larger market share of transdermal drug delivery system owing to the increase in cases of heart-related disorders.


Geographically, transdermal drug delivery systems market is segmented as North America, Latin America, Europe, Asia Pacific and Middle East & Africa. Asia Pacific is expected to dominate transdermal drug delivery system industry owing to the growing number of patients suffering from chronic disorders. The prominent players in transdermal drug delivery systems industry include Acrux Limited, Echo Therapeutics, Inc., Johnson & Johnson, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Mylan N.V., Bayer AG, Endo Pharmaceuticals Inc. and Novartis AG.


Browse Full Research Report with TOC:  https://www.millioninsights.com/industry-reports/transdermal-drug-delivery-system-market


Market Segment:


Global Transdermal Drug Delivery Systems Product Outlook (Revenue, USD Billion, 2013 - 2024)

    • Electroporation

    • Radiofrequency

    • Iontophoresis

    • Microporation

    • Thermal

    • Mechanical arrays

    • Ultrasound

    • Others


Global Transdermal Drug Delivery Systems Application Outlook (Revenue, USD Billion, 2013 - 2024)

    • Central nervous system

    • Pain management

    • Cardiovascular

    • Hormone

    • Others


Transdermal Drug Delivery Systems Regional Outlook (Revenue, USD Billion, 2013 - 2024)

    • North America

        • U.S.

        • Canada

    • Europe

        • UK

        • Germany

    • Asia Pacific

        • Japan

        • China

        • India

    • Latin America

        • Mexico

        • Brazil


continue........


Get In Touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.


Contact Person: 

Ryan Manuel

Research Support Specialist, USA

Email: ryan@millioninsights.com


Global Headquarters

Million Insights

Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States

Phone: 1-408-610-2300

Email: sales@millioninsights.com


Asia Pacific

Million Insights

Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India

Phone: 91-20-65300184

 

 


Comments

Post a Comment

Popular posts from this blog

Global and Chinese Bufexamac Market Outlook and Analysis 2019 to 2022

15-mar-2019 The Bufexamac Market 2017 Report offers detailed analysis of the Bufexamac market over the last five years, and provides extensive market forecasts by region/country and sub sector. It covers the key technological and market trends in the Bufexamac market. It further lays out an analysis of the factors influencing the supply/demand for Bufexamac, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies. In particular, it provides an in-depth analysis of the following: Market overview: detailed analysis of the whole value chain (upstream & downstream), insights into technological developments, and an extensive analysis of costs analysis from the aspects of raw materials, labor costs and etc. Market size and driving factors: comprehensive analysis of the global Bufexamac market...
Read more

Global Diabetes Care Products Market Study 2016-2022

14-mar-2019 In this report, the global Diabetes Care Products market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Diabetes Care Products for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global Diabetes Care Products market competition by top manufacturers/players, with Diabetes Care Products sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including BD Bayer Abbott B. Braun Medtronic Tandem Diabetes Care Insulet Corporation Roche J&J ARKRAY Inc Ypsomed Sannuo Sanofi On the basis of product, this report displays the production, revenue, price, market share and growth rate of each ...
Read more

Antidiabetic Biguanides Market Survey - Global Industry Share, Size, Trends and Forecasts, 2017

This report studies sales (consumption) of Antidiabetic Biguanides in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering • Anderson Hay & Grain Inc. • Border Valley • Sanofi • Takeda Pharmaceuticals • Eli Lilly • Merck & Co. • Novo Nordisk Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/global-antidiabetic-biguanides-sales-market-report-2017/request-sample Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Antidiabetic Biguanides in these regions, from 2011 to 2021 (forecast), like • United States • China • Europe • Japan • Southeast Asia • India Split by product Types, with sales, revenue, price and gross margin, market share and growth rat...
Read more